MedPath

The interaction between glycemic control and sleep characteristics in patients with type 1 Diabetes Mellitus

Conditions
diabetes
glucose metabolism disorders
10018424
Registration Number
NL-OMON34292
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Informed consent
DM1 on stable continuous subcutaneous insulin infusion
HbA1c levels <8.0% during the year prior to the start of the study
Non-smoking
Age >18 and <65 years
Coffee <4 U/day
Alcohol <2 U/day

Exclusion Criteria

•Presence of sleep disorders determined by validated sleep questionnaires (Pittsburg sleep quality index (PSQI), Epworth Sleepiness scale (ESS), and Berlin Questionnaire (BQ)
•Psychiatric disorders and/or use antipsychotic or antidepressant drugs at present
•Nights shifts within the last 3 months
•Pregnancy
•Chronic use of sleep medication and/or melatonin
•Use of medication known to affect glucose metabolism (e.g. prednisone, beta-blocking agents)
•Use of prokinetic drugs or aspirin
•Renal, hepatic or other endocrine disease
•Traveling across time zones < 4 weeks before the study
•History of cardiac disorders
•Difficulty to insert an intravenous catheter

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath